CESSATECH A/S DK -20
Research CESSATECH A/S DK -20 (8GN) on Bullrun: market cap EUR 42.91M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker8GN
- ExchangeF
- CountryDenmark
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 42.91M
- Financial periodQ4 2025
- RevenueEUR 9.45M
- Net income-EUR 773.00K
- Free cash flow-EUR 300.00K
Valuation Snapshot
latest market cap is EUR 42.91M.
About CESSATECH A/S DK -20
Cessatech A/S, a pivotal-stage pediatric biotech company, develops specialty hospital medicines for children in Denmark. Its lead candidate product is CT001, a fixed-dose nasal spray for treating acute pain in children. The company also develops CT002, a non-invasive intranasal sedation for children undergoing medical procedures in Phase 2 clinical trials; and CT003, a topical anesthetic in pre-clinical development.
Frequently asked questions
What is CESSATECH A/S DK -20's market cap?
CESSATECH A/S DK -20's market capitalization is EUR 42.91M.
What does CESSATECH A/S DK -20 do?
Cessatech A/S, a pivotal-stage pediatric biotech company, develops specialty hospital medicines for children in Denmark. Its lead candidate product is CT001, a fixed-dose nasal spray for treating acute pain in children.